Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0700
0.00 (0.00%)
Feb 9, 2026, 1:12 PM EST
Oncotelic Therapeutics Market Cap
Oncotelic Therapeutics has a market cap or net worth of $28.7 million as of February 10, 2026. Its market cap has increased by 105.16% in one year.
Market Cap
28.70M
Enterprise Value
41.19M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since April 23, 2019, Oncotelic Therapeutics's market cap has increased from 9.14M to 28.70M, an increase of 213.92%. That is a compound annual growth rate of 18.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 28.70M | -22.69% |
| Dec 31, 2025 | 37.13M | 160.46% |
| Dec 31, 2024 | 14.26M | -6.64% |
| Dec 29, 2023 | 15.27M | -13.24% |
| Dec 30, 2022 | 17.60M | -71.94% |
| Dec 31, 2021 | 62.72M | 225.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VitaSpring Biomedical | 51.78M |
| Vicapsys Life Sciences | 48.56M |
| Cell Source | 43.94M |
| ZIVO Bioscience | 40.77M |
| Arch Biopartners | 39.22M |
| Harvard Apparatus Regenerative Technology | 31.65M |
| Finch Therapeutics Group | 22.00M |
| EOM Pharmaceuticals Holdings | 17.71M |